EBT Share Purchase
RNS Number : 0178MSynectics PLC13 July 2026
13 July 2026
![]()
Synectics plc
("Synectics", the "Company" or the "Group")
EBT Share Purchase
Synectics plc (AIM: SNX), a leader in advanced security and surveillance solutions, announces that it was notified on 10 July 2026 that Quadnetics Employees' Trustees Limited (the "Trustee"), the trustee of the Company's employee benefit trust, Synectics Plc Employees' Trustees Limited (the "EBT"), had acquired 32,500 of the Company's ordinary shares of 20p each ("Ordinary Shares") at a weighted average price of 201.3846 pence per Ordinary Share.
The acquired Ordinary Shares were purchased by Singer Capital Markets in accordance with a trading plan between it and the Trustee.
The acquired Ordinary Shares will be held by the Trustee for the purposes of the EBT transferring the Ordinary Shares to employees of the Company when options are exercised.
Following the above transactions, the EBT holds 974,836 Ordinary Shares, representing approximately 5.5% of the Company's issued share capital.
For further information, please contact:
Synectics plc
Amanda Larnder, Chief Executive Officer
Paul Williams, Chief Financial Officer
Claire Stewart, Company Secretary
email: info@synecticsplc.com
Tel: +44 (0) 114 280 2828
Singer Capital Markets
Tel: +44 (0) 20 7496 3000
Jen Boorer / James Fischer / Patrick Weaver
About Synectics plc
Synectics plc (AIM: SNX) is a leader in advanced security and surveillance solutions that help protect people, property and assets around the world.
It transforms customer operations by seamlessly integrating systems, technologies, and data into a unified solution-enhancing safety, improving efficiency, and enabling smarter, faster decision-making and response capabilities.
With its technical expertise, decades of experience, and strong partnerships, Synectics sets itself apart by delivering innovation and service that drive real value and long-term success.
Find out more at www.synecticsplc.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDMSCUUOBRNRUBAAR
